$50MSeries D, 9 April 2026
Boehringer Ingelheim invested $50M and transferred full commercial rights to CT-155 to Click.
- Amount
- $50M
- Stage
- Series D
- Announced
- 9 April 2026
- Lead
- Boehringer Ingelheim
- Use of funds
- Boehringer Ingelheim invested $50M and transferred full commercial rights to CT-155 to Click.
- Checked
- Announced by the company
- Sources
- Click Therapeutics gets $50M Series D investment from Boehringer Ingelheim hitconsultant.net
Click Therapeutics gets $50M Series D investment from Boehringer Ingelheim ventureburn.com